Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -16.62% | 401.85% | 401.85% | 401.85% |
| Total Revenue | -- | -16.62% | 401.85% | 401.85% | 401.85% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -16.62% | 401.85% | 401.85% | 401.85% |
| SG&A Expenses | -8.67% | -4.54% | -0.37% | -6.10% | -11.15% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -8.67% | -4.54% | -0.37% | -6.10% | -11.15% |
| Operating Income | -82.66% | -0.66% | 45.34% | 48.51% | 51.26% |
| Income Before Tax | 104.65% | 34.43% | -316.52% | -276.22% | -248.15% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 104.65% | 34.43% | -316.52% | -276.22% | -248.15% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 104.65% | 34.43% | -316.52% | -276.22% | -248.15% |
| EBIT | -82.66% | -0.66% | 45.34% | 48.51% | 51.26% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 18.38% | -105.27% | -678.22% | -397.62% | -209.93% |
| Normalized Basic EPS | 22.22% | 26.32% | 30.00% | 58.97% | 68.97% |
| EPS Diluted | 18.38% | -105.27% | -678.22% | -397.62% | -209.93% |
| Normalized Diluted EPS | 22.22% | 26.32% | 30.00% | 58.97% | 68.97% |
| Average Basic Shares Outstanding | -50.00% | -48.63% | -47.28% | -23.83% | -0.02% |
| Average Diluted Shares Outstanding | 3.52% | 4.48% | 5.43% | 2.72% | -0.02% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |